left hemiparesis. On examination, the child was drowsy, but obeying commands. There was bilateral established papilledema, left upper motor neuron facial palsy and hemiparesis. The Glasgow coma scale was E3M6V2. The child had aspiration pneumonia on admission. Cranial magnetic resonance imaging (MRI) revealed a large right-sided parieto-occipital lesion extending to ventricles with superior sagittal sinus compression ( Figure 1A) . Areas of contrast enhancement were seen towards the side with dural attachment ( Figure  1B ). There were multiple foci of calcification within the tumor. Right parieto-occipital craniotomy and gross total excision of tumor was done. Bone was thin and the dura was tense. The soft, grayish-white tumor with necrotic areas had breached the dura near the midline. There was no plane between the superior sagittal sinus and the tumor in the posterior third. There were firm areas in between and areas of calcification.
█ INTRODUCTION E mbryonal tumor with multilayered rosettes (ETMR) is a new entity among the embryonal tumors of the central nervous system (CNS), included as a separate entity in the World Health Organization (WHO) classification of CNS tumors, 2016. The tumors which were previously referred to as embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma and medulloepithelioma are now included under this heading (5) . Large case series of ETMR are very few and description of each case would add to the existing knowledge on the natural history and prognostic indicators of this rare tumor. So, we report a case of ETMR in a 3-year-old girl who succumbed to the illness in the immediate postoperative period.
█ CASE REPORT
A 3-year-old girl was referred to the neurosurgical services with features of increased intracranial pressure. There was history of increased tiredness in the child and vomiting for three months. The parents consulted a pediatrician who detected Mitotic activity was brisk. In the neuropil areas larger cells with vesicular nuclei and indistinct cytoplasmic borders were seen. In a single low power focus we could appreciate multilayered ependymoblastic rosettes merging into the neuropil areas ( Figure 2E ). Scattered ganglion cells were noted within the neuropil areas ( Figure 2F ). Immunohistochemistry showed the cells to be positive for vimentin. The neuropil was positive for synaptophysin ( Figure 2E, inset) . A diagnosis of embryonal tumor with multilayered rosettes was made. . This is a rare tumor which occurs mostly in the cerebral cortex of children below the age of four years and has a poor prognosis (1, 7) . A female preponderance is described. On imaging, the tumors are usually large solid masses with or without a cystic component and patchy or no contrast enhancement in spite of the higher grade (1, 4) . In the present case also the tumor was in a girl child and was large with contrast enhancement. Many cases are reported to have dural attachment as the present one (1).
Histopathologically the hallmark of ETMR is the presence of ependymoblastic rosettes and undifferentiated small cells with or without neoplastic neuropil. There is as yet no criterion on the proportion of tumor tissue with rosettes that is necessary to make a diagnosis of ETMR and it would be worthwhile to study the relevance of this proportion on the course of the disease. In the present case but for the single focus of ependymoblastic rosettes the tumor would have been labeled simply as a CNS embryonal tumor. The unresponsiveness of ETMR to current treatment protocols makes it necessary to differentiate it from other embryonal tumors (7, 8) . Immunohistochemically the tumor cells are positive for vimentin and the neuropil is positive for synaptophysin. MIB-1 labeling index will be very high as for all embryonal tumors.
The breakthrough discovery of a hallmark cytogenetic abnormality ie, focal amplification of miRNA cluster at chromosome locus 19q13.42 was made in these tumors by Korshunov et al. and Pfister et al. (6, 11) . As there was considerable debate regarding the existence of a separate entity as 'ependymoblastoma', it was prudent to put ETANTR and ependymoblastoma into a single entity with the discovery of this amplification (10) . C19MC amplification or fusion defines the tumor now. LIN28A was identified as a specific marker by gene expression profiling and antibodies were developed for immunohistochemical diagnosis of the tumor (2,7). With widespread availability of this marker, more cases will be diagnosed. We could not do immunohistochemistry or gene amplification studies as the facilities are not available at our centre.
█ CONCLUSION
The differences in survival and prognostic factors between ETMR and other CNS embryonal tumors and the need to differentiate them in terms of treatment and prognostication have not as yet been clearly defined. Large series of cases have to be studied to precisely determine these variables. Therefore reporting each case with the morphological features of this tumor would add to the existing data on these tumors as regards pathology, diagnosis and management.
